OSL oncosil medical ltd

2.43%

$1.01

Thanks TT for your considered views. I would also add that FDA...

First 9 Last

Share
Profile

Follow
Gekkowolf

2,588 Posts.

257

02/02/22

13:44

Post #: 59301277
Share

Originally posted by tinyteddy: ↑

I hate to think.

Approval for anything from FDA is a big sign to the market that the product has enormous potential. So while the sales from the HDE approval won;t be huge, the impact on the acceptance of the company will be. In a sense, FDA are looking at the Panco study and deciding if they think there is good safety data and potential for effectiveness. They still need a randomised trial to approve it for pancreatic cancer, but allowing its use in any way means that think its safe and see the value of it based on current work. Which is worth a lot.

I'm still encouraged by the presentations on file at FDA where they have already classified under what regulations oncosil would be approved.

I'm also still of a view that the indication "distal cholangiocarcinoma" is really just a backdoor indication for some pancreatic cancers. However, there is effectively no treatment for cholangiocarcinoma, so it lowers the bar in terms of approval. I guess thats why it was chosen.

Getting approved in any capacity means US doctors get to see it and use it occasionally, which is extremely important, as the funds in the US for research are vast.

So, in summary, I guess that not getting approved wouldn't mean that much in terms of sales, but it would in terms of reputation. And that would affect its ability to raise capital from the US.

Expand

Thanks TT for your considered views. I would also add that FDA approval for bile duct cancer would make eventual sales in the US more easy since Medicare reimbursement would be available. So, I think getting FDA approval for bile duct would be a huge boost for Oncosil.

OSL Price at posting: 4.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

PIQ

Proteomics notches up as company launches PromarkerD into the US

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.01		Change -0.025(2.43%)		Mkt cap ! $14.29M

Open	High	Low	Value	Volume
$1.04	$1.05	$1.00	$41.05K	40.86K

Buyers (Bids)

No.	Vol.	Price($)
1	500	$1.01

Sellers (Offers)

Price($)	Vol.	No.
$1.05	1249	1

View Market Depth

No.	Vol.	Price($)
1	17640	1.000
1	1000	0.990
1	2875	0.980
2	6000	0.970
1	1000	0.960

Price($)	Vol.	No.
1.045	1249	1
1.050	25048	2
1.075	1879	1
1.090	375	1
1.180	2500	1

Last trade - 15.47pm 20/06/2025 (20 minute delay)

OSL (ASX) Chart

Thanks TT for your considered views. I would also add that FDA...

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

AML3D opens new facility in Ohio as US Defence strategy bears fruit

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Proteomics notches up as company launches PromarkerD into the US

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks TT for your considered views. I would also add that FDA...

Top Stories

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

AML3D opens new facility in Ohio as US Defence strategy bears fruit

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Proteomics notches up as company launches PromarkerD into the US

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News